Ling Zhao

Statistics

Publications

Citations

427

H-Index

Active since

2006

Affiliations

National Human Genome Research Institute(Current)

National Institutes of Health

National Cancer Institute

University of Pennsylvania

University of Nebraska Medical Center

Ling Zhao is an author at National Human Genome Research Institute specializing in medicine, molecular oncology, and myeloid-derived suppressor cells.

ORCID

Publications per year

2006–2021

Publications

Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1–CBFβ interaction

Lea Cunningham, Steven Finckbeiner, R. Katherine Hyde et al. · Proceedings of the National Academy of Sciences · 2012 · 135 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Cbfb/Runx1 repression–independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11

R. Katherine Hyde, Yasuhiko Kamikubo, Stacie M. Anderson et al. · Blood · 2009 · 51 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +9

KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice

Ling Zhao, J. Joseph Melenhorst, Lemlem Alemu et al. · Blood · 2011 · 46 citations · Full text

Medicine, Genetics, Oncology +8

Accelerated Leukemogenesis by Truncated CBFβ-SMMHC Defective in High-Affinity Binding with RUNX1

Yasuhiko Kamikubo, Ling Zhao, Mark Wunderlich et al. · Cancer Cell · 2010 · 46 citations · Full text

Medicine, Hematology, Oncology +5

RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development

Tao Zhen, Yaqiang Cao, Gang Ren et al. · Blood · 2020 · 40 citations · Full text

Medicine, Genetics, Molecular Genetics +15

1–5 of 10